MedTrace Logo

Oxycodone Pharmacokinetics in Preterm Infants

NCT02564003 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2015-09-30

No results posted yet for this study

Summary

The pharmacokinetics of oxycodone is well characterized in children older than six months of age. However, only one study has been published with children younger than six months, concluding that unexplained inter-individual variability is pronounced in the youngest children. The aim of the current study was to quantify oxycodone pharmacokinetics in children ranging from preterm newborn infants to children up to two years of age.

Conditions

Interventions

DRUG

Oxycodone

oxycodone 0,1 mg/kg iv

Sponsors & Collaborators

  • Admescope Ltd

    collaborator INDUSTRY

  • Kuopio University Hospital

    lead OTHER

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-08-31
Completion
2013-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02564003 on ClinicalTrials.gov